Entirety Biomedical develops and manufactures novel absorbable metal implants under the Curasorb Alloy brand, engineered to match the performance and simple implantation procedures of traditional titanium implants while safely absorbing once healing is complete. The technology eliminates lifelong concerns, complications, discomfort, and costs associated with permanent hardware left in the body. Curasorb implants target cosmetic, trauma, and orthopedic reconstruction procedures including maxillofacial and extremity fixation, offering surgeons a temporary implant solution with permanent peace of mind.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2026
Create a free account to see which investors have funded this company.
Create Free AccountGlobal contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...